Tag: CRISPR Therapeutics AG (NASDAQ:CRSP)

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Until today this year the stock’s price performance recorded a decrease of -24.12%. However, over the last

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. CRISPR Therapeutics AG’s current trading price is -32.63% away from its 52-week high, while its distance from the 52-week low